Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin
Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin
Sponsor: Beijing Center for Disease Control and Prevention
A PHASE4 clinical study on Chickenpox and Zoster, this trial is completed. The trial is conducted by Beijing Center for Disease Control and Prevention and has accumulated 4 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Center for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .